全文获取类型
收费全文 | 11329篇 |
免费 | 1060篇 |
国内免费 | 314篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 237篇 |
妇产科学 | 243篇 |
基础医学 | 1414篇 |
口腔科学 | 202篇 |
临床医学 | 1268篇 |
内科学 | 2120篇 |
皮肤病学 | 147篇 |
神经病学 | 619篇 |
特种医学 | 369篇 |
外科学 | 1658篇 |
综合类 | 915篇 |
现状与发展 | 2篇 |
一般理论 | 2篇 |
预防医学 | 834篇 |
眼科学 | 352篇 |
药学 | 926篇 |
1篇 | |
中国医学 | 322篇 |
肿瘤学 | 992篇 |
出版年
2024年 | 16篇 |
2023年 | 125篇 |
2022年 | 227篇 |
2021年 | 374篇 |
2020年 | 274篇 |
2019年 | 303篇 |
2018年 | 347篇 |
2017年 | 282篇 |
2016年 | 289篇 |
2015年 | 386篇 |
2014年 | 476篇 |
2013年 | 489篇 |
2012年 | 773篇 |
2011年 | 821篇 |
2010年 | 480篇 |
2009年 | 444篇 |
2008年 | 685篇 |
2007年 | 647篇 |
2006年 | 602篇 |
2005年 | 620篇 |
2004年 | 518篇 |
2003年 | 471篇 |
2002年 | 392篇 |
2001年 | 289篇 |
2000年 | 291篇 |
1999年 | 291篇 |
1998年 | 154篇 |
1997年 | 119篇 |
1996年 | 107篇 |
1995年 | 97篇 |
1994年 | 88篇 |
1993年 | 64篇 |
1992年 | 140篇 |
1991年 | 113篇 |
1990年 | 117篇 |
1989年 | 89篇 |
1988年 | 91篇 |
1987年 | 92篇 |
1986年 | 78篇 |
1985年 | 61篇 |
1984年 | 42篇 |
1983年 | 42篇 |
1982年 | 43篇 |
1981年 | 28篇 |
1980年 | 16篇 |
1979年 | 32篇 |
1978年 | 19篇 |
1976年 | 19篇 |
1972年 | 16篇 |
1970年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
51.
Onnen Grauhan Henryk Siniawski Michael Dandel Hans Lehmkuhl Christoph Knosalla Miralem Pasic Yu-Guo Weng Roland Hetzer 《European journal of cardio-thoracic surgery》2007,32(4):634-638
OBJECTIVE: Due to the shortage of donor hearts, the criteria for organ acceptability have been considerably extended and donor grafts with coronary atherosclerosis are among those offered. This study evaluated whether and to what degree pre-existing coronary atherosclerosis may be acceptable. METHODS: A total of 1253 consecutive HTx recipients were investigated retrospectively for donor-transmitted coronary atherosclerosis (DCAS). Donor-transmitted coronary atherosclerosis was defined as focal atherosclerosis with stenosis of at least 50%. Inclusion criteria were absence of pre-HTx angiogram but performance of angiogram or autopsy within 6 months after heart transplantation. Kaplan-Meier analysis and log-rank test were used. RESULTS: Eighty-five out of 1253 (6.8%) cases were excluded, since coronary evaluation was not performed within 6 months (n=45) or hearts had undergone pre-transplant angiography (n=40). In 1086 patients no donor-transmitted coronary atherosclerosis was found (NDCAS group) and in 82 patients (7%) donor-transmitted coronary atherosclerosis was diagnosed by angiography (n=49) or autopsy (n=33). Single-vessel donor-transmitted coronary atherosclerosis was found in 53/82 patients (DCAS1 group) and double- or triple-vessel donor-transmitted coronary atherosclerosis in 26/82 patients (DCAS2/3 group). Three of the 82 patients with donor-transmitted coronary atherosclerosis were excluded since the autopsy report was unclear regarding degree of atherosclerosis. Early after heart transplantation the 30-day mortality in the NDCAS and DCAS1 groups was 12.2% versus 13.2% whereas in the DCAS2/3 group it was 61.5%. Beyond the first year the annual decrease with and without donor-transmitted coronary atherosclerosis (single-vessel disease) is comparable. CONCLUSIONS: Donor screening without coronary angiogram overlooks significant atherosclerotic lesions in a considerable number of cases (7.0%). Therefore, angiographic donor screening should be performed. Donor grafts with single-vessel coronary atherosclerosis may be accepted as marginal hearts; however, in our opinion, revascularisation (CABG, PTCA) should be considered. Grafts with two- or even three-vessel coronary atherosclerosis seem to have a serious risk for early graft failure. Beyond the first year the outcome of healthy grafts and grafts with donor-transmitted coronary atherosclerosis seems to be comparable. 相似文献
52.
A. I. Fink A. J. Jordan P. N. Lao D. A. Fong 《The British journal of ophthalmology》1988,72(4):263-269
Sixty-one patients (82 eyes) were studied after argon laser trabeculoplasty (ALT) to determine the lasting efficacy of such treatment. This investigation, now in its fourth year, was prospective, and the information derived was analysed with the aid of a computer. Success was defined as intraocular pressure (IOP) below baseline (22 mmHg). The mean follow-up time was 24.5 months, when the success rate was 74% compared with 75% at three months. Success declined to 45% at 42 months. No significant difference was noted when (a) first lasered eyes of all patients and those fellow eyes treated were analysed separately, (b) when right and left eyes were analysed separately, nor (c) when patients were divided into two treatment groups, (I) 100 burns at 1 W, and (II) 65 burns at 850 mW. Eight of 11 eyes showed progressive postlaser field loss despite below-baseline intraocular pressures. ALT is an alternative to carbonic anhydrase inhibitor therapy, with a success rate of 66.7% at two years. However, repeat ALT was successful in only 25% of patients seven months after treatment. 相似文献
53.
(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, HPMPC, and two HPMPC-related nucleoside analogs, (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine, HPMPA, and (2-phosphonylmethoxyethyl)guanine, PMEG, were evaluated for their antiviral activities against guinea pig cytomegalovirus (GPCMV) infection in guinea pig embryo (GPE) cells and human cytomegalovirus (HCMV) infection in human diploid fibroblast (MRC-5) cells. DHPG, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, was used for comparison. The antiviral activity of HPMPC against GPCMV infection in vivo and its toxicity to Hartley guinea pigs were also evaluated. The 50% antiviral effective doses (ED50) of HPMPC, HPMPA, PMEG and DHPG against GPCMV infection in GPE cells were 0.22, 1.4, 0.07 and 62 microM, respectively; and against HCMV infection in MRC-5 cells, the ED50s were 0.51, 0.72, 0.01 and 17.5 microM, respectively. Their cytotoxic doses (CyD50) in GPE replicating cells were 84, 35, 1.4 and 700 microM, respectively and in MRC-5 cells were approximately 114, 31, 0.86 and 750 microM, respectively. Based on their calculated therapeutic indexes, HPMPC was the most potent and selective of the four compounds tested. In vivo, during acute infection, the spleen indexes of all infected animals that were treated with 1.25 to 5.0 mg/kg/day of HPMPC for 5 days were significantly reduced as compared with sham-treated animals. Virus infectivity titers in blood and various tissues of infected animals treated with HPMPC, 2.5 or 1.25 mg/kg/day were not significantly lower than those of the infected, sham-treated animals; with 5 mg/kg/day, infectivity titers in the blood, spleen, and salivary gland were significantly lower in HPMPC-treated than in sham-treated animals. However, HPMPC was toxic to guinea pigs especially at doses of 5 to 10 mg/kg/day. These data showed that HPMPC was highly active and selective in cultured guinea pig cells and human fibroblast cells against CMV infection but did not effectively inhibit GPCMV infection in guinea pigs at minimum toxic concentrations. 相似文献
54.
Three rare cases of upper eyelid trauma are presented. In high-speed traffic accidents, the upper eyelids were penetrated by glass, avulsed, and then, together with pieces of glass, pushed over the globe and buried deeply in the retrobulbar area. The invaginated eyelids were pulled out gently, the conjunctiva still attached to the globes. They were repaired primarily. In these patients eyelid function and cosmesis were preserved. 相似文献
55.
本文测试了40例健康成人(男女各半)刺激腕正中神经和踝部胫后神经的短潜期体感诱发电位(SLSEPs),结果如下:1.SLSEPs多数PLs女性均较男性为短,这主要与肢长、身高有关,2.提供了SLSEPs的正常值,可供参考,3.检测SLSEPs对某些神经病损的定位诊断、治疗和预后的判断有重要临床意义。 相似文献
56.
纳米技术是20世纪80年代末期兴起的新技术。此种新技术是指在1-100nm这一尺度范围内对原子和分子运动规律和特性进行研究和应用。通过直接操纵和安排原子、分子将物质转变成具有特殊性能的新材料的科学技术。纳米技术研究的最终目标是直接以原子和分子为起点,从纳米材料出发或采用纳米加工技术,制造出具有特殊功能的产品,从而改变人类的生产和生活模式。纳米科技保健产品对促进人类健康有积极作用。 相似文献
57.
Radiologic and pathologic mani;estations of 30
peripheral pulmonary masses around l.5-3 cm in dia-
meter were compared to the pathologic basis of va-
cuole sign and small node sign on tomogram. Stati
stics of 100 conventional X-ray tomograms of peri-
pheral pulmonary masses about l-3 cm in diameter
suggested that the vacuole sign and small node sign,
more common in early peripheral lung cancer than
in tuberculoma, are valuable for differentiating early
peripheral lung cancer from tuberculoma. 相似文献
58.
59.
60.
宫颈粘液过氧化物酶在月经周期中的变化规律 总被引:3,自引:1,他引:2
本文对29例月经周期正常妇女的宫颈粘液过氧化物酶进行了30个周期的研究。在月经周期不同时间测定宫颈粘液过氧化物酶(CMPx)活性及血清促黄体生成素(LH)、雌二醇(E_2)和孕酮(P)。结果表明:在排卵前三天酶活性明显下降,至排卵后一天开始上升。卵泡期,酶活性与E_2呈负相关(r=-0.67);黄体期,酶活性与P呈正相关(r=0.79)。本研究提示:1.CMPx在排卵周期具有特定的变化规律,其变化受体内激素水平影响,可作为预告排卵的指标。2.如简化测定方法,可为自然避孕提供新途径。 相似文献